Filing Flows › Pharma-Bio Serv (PBSV) › Capital expenditures
Pharma-Bio Serv (PBSV) capital expenditures by quarter
Pharma-Bio Serv's capital expenditures were $1K in Q3 FY26 (third quarter fiscal 2026), +297% from Q4 FY25. Over the last 4 quarters it ranged from $350 (Q4 FY25) to $157K (Q4 FY24).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $1K | +297% | -32% |
| Q4 FY25 | $350 | -83% | -100% |
| Q3 FY25 | $2K | -99% | — |
| Q4 FY24 | $157K | — | — |
Q3 FY26 at a glance
Pharma-Bio Serv, Q3 FY26: revenue $2.3M (+19% year over year), operating margin -3.1%, net loss $14K, operating cash flow $61K. The chart follows the revenue to costs, profit and cash.
Questions
What is Pharma-Bio Serv's capital expenditures?
Pharma-Bio Serv's capital expenditures were $1K in Q3 FY26 (third quarter fiscal 2026), +297% from Q4 FY25.
How has Pharma-Bio Serv's capital expenditures changed?
Over the last 4 quarters it ranged from $350 (Q4 FY25) to $157K (Q4 FY24).